cancer tumour
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with histologically proven carcinoma of the prostate, rectum, esophagus, lung, breast, head and neck, gastric-, bladder- anal and gynaecological cancer, liver-, lung- and soft tissue oligo-metastases (adrenal glands, abdominal lymph nodes), brain tumors and sarcoma patients will be included.
Exclusion criteria
Exclusion criteria: Contra*indications for a MRI examination Patients with previous allergic reaction to infusion of contrast media (Gadolinium-based) Patients with WHO performance status >2 Claustrophobia Patients >140 kg and/or a body with > 60 cm
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To optimize MR-sequence protocols for MR-guided radiotherapy, using the integrated Phillips MRI scanner of the MRL system | — |
Secondary
| Measure | Time frame |
|---|---|
| • Demonstrate the feasibility of acquiring clinically usable images with clear visualization of the tumor and organs at risk (OAR) for image guidance with the MRI scanner integrated in the MRL system. • Selection of optimum imaging sequences for image-registration and (auto)contouring of the tumor and OAR for adaptive re-planning. • To monitor changes in target volume, target position and inter-/intra-fraction motion of the tumor and OAR during radiotherapy with serial MR images, to establish the need of adaptive re-planning during the course of treatment on an MRL. • To establish an estimate on the variation in functional MRI parameters during radiation therapy. • To develop an optimal MRL workflow for online MRI-guided adaptive radiotherapy. | — |
Countries
Netherlands